MXPA03009278A - Farmacos antiangiogenicos peptidos. - Google Patents
Farmacos antiangiogenicos peptidos.Info
- Publication number
- MXPA03009278A MXPA03009278A MXPA03009278A MXPA03009278A MXPA03009278A MX PA03009278 A MXPA03009278 A MX PA03009278A MX PA03009278 A MXPA03009278 A MX PA03009278A MX PA03009278 A MXPA03009278 A MX PA03009278A MX PA03009278 A MXPA03009278 A MX PA03009278A
- Authority
- MX
- Mexico
- Prior art keywords
- antiangiogenic drugs
- peptide
- peptide antiangiogenic
- angiogenesis
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invencion expone peptidos que son utiles en la inhibicion de angiogenasis. Tambien se exponen composiciones inhibidoras de angiogenesis y metodos para la inhibicion de angiogenesls en un mamifero.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/832,733 US20020183242A1 (en) | 2001-04-11 | 2001-04-11 | Peptide antiangiogenic drugs |
PCT/US2002/011027 WO2002083065A2 (en) | 2001-04-11 | 2002-04-10 | Peptide antiangiogenic drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03009278A true MXPA03009278A (es) | 2004-03-10 |
Family
ID=25262479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03009278A MXPA03009278A (es) | 2001-04-11 | 2002-04-10 | Farmacos antiangiogenicos peptidos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20020183242A1 (es) |
EP (1) | EP1429796A4 (es) |
JP (1) | JP2005510452A (es) |
AU (1) | AU2002303278A1 (es) |
BR (1) | BR0205983A (es) |
CA (1) | CA2443733A1 (es) |
MX (1) | MXPA03009278A (es) |
PE (1) | PE20021078A1 (es) |
UY (1) | UY27254A1 (es) |
WO (1) | WO2002083065A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030045477A1 (en) * | 2001-07-26 | 2003-03-06 | Fortuna Haviv | Peptides having antiangiogenic activity |
KR101373140B1 (ko) * | 2005-03-03 | 2014-03-12 | 씨오브이엑스 테크놀로지스 아일랜드 리미티드 | 항-혈관형성 화합물 |
WO2013055385A2 (en) | 2011-10-03 | 2013-04-18 | Zafgen Corporation | Methods of treating age related disorders |
CA2777108A1 (en) | 2009-10-09 | 2011-04-14 | Zafgen Corporation | Sulphone compounds and methods of making and using same |
WO2011085198A1 (en) | 2010-01-08 | 2011-07-14 | Zafgen Corporation | Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph) |
US20130023513A1 (en) | 2010-01-12 | 2013-01-24 | Hughes Thomas E | Methods and Compositions for Treating Cardiovascular Disorders |
WO2011127304A2 (en) | 2010-04-07 | 2011-10-13 | Zafgen Corporation | Methods of treating an overweight subject |
EP2595988B1 (en) | 2010-07-22 | 2014-12-17 | Zafgen, Inc. | Tricyclic compounds and methds of making and using same |
WO2012064928A1 (en) | 2010-11-10 | 2012-05-18 | Zafgen Corporation | Methods and compositions for treating thyroid hormone related disorders |
WO2012074968A1 (en) | 2010-11-29 | 2012-06-07 | Zafgen Corporation | Methods of reducing risk of hepatobiliary dysfunction during rapid weight loss with metap-2 inhibitors |
US9189078B2 (en) | 2010-12-20 | 2015-11-17 | Apple Inc. | Enhancing keycap legend visibility with optical components |
WO2012103333A1 (en) | 2011-01-26 | 2012-08-02 | Zafgen Corporation | Tetrazole compounds and methods of making and using same |
CA2835195A1 (en) | 2011-05-06 | 2012-11-15 | Zafgen, Inc. | Tricyclic sulfonamide compounds and methods of making and using same |
EP2705030B1 (en) | 2011-05-06 | 2016-07-27 | Zafgen, Inc. | Partially saturated tricyclic compounds and methods of making and using same |
WO2012154679A1 (en) | 2011-05-06 | 2012-11-15 | Zafgen Corporation | Tricyclic pyrazole sulfonamide compounds and methods of making and using same |
KR20140112566A (ko) | 2012-01-18 | 2014-09-23 | 자프겐 인크. | 삼환식 설폰 화합물 그리고 그의 제조방법 및 그를 이용하는 방법 |
EP2804866B1 (en) | 2012-01-18 | 2016-11-16 | Zafgen, Inc. | Tricyclic sulfonamide compounds and methods of making and using same |
BR112014028041A2 (pt) | 2012-05-08 | 2017-06-27 | Zafgen Inc | tratamento de obesidade hipotalâmica com inibidores de metap2 |
JP6177888B2 (ja) | 2012-05-09 | 2017-08-09 | ザフゲン,インコーポレイテッド | フマギロール型化合物ならびにその製造および使用方法 |
JP6169716B2 (ja) | 2012-11-05 | 2017-07-26 | ザフゲン,インコーポレイテッド | 肝疾患を治療する方法 |
BR112015010225A2 (pt) | 2012-11-05 | 2017-07-11 | Zafgen Inc | compostos tricíclicos e seus métodos de produção e utilização |
KR20150080614A (ko) | 2012-11-05 | 2015-07-09 | 자프겐 인크. | 비만의 치료 및/또는 제어에서 사용하기 위한 트리시클릭 화합물 |
CN105228610A (zh) | 2013-03-14 | 2016-01-06 | 扎夫根股份有限公司 | 治疗肾疾病和其它病症的方法 |
CN106432255A (zh) | 2015-08-11 | 2017-02-22 | 扎夫根公司 | 烟曲霉素醇螺环化合物和制备和使用其的方法 |
AR105671A1 (es) | 2015-08-11 | 2017-10-25 | Zafgen Inc | Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200937A (en) * | 1988-09-29 | 1993-04-06 | Canon Kabushiki Kaisha | Apparatus for and method of recording and/or reproducing information by means of two actuators |
US5192744A (en) * | 1990-01-12 | 1993-03-09 | Northwestern University | Method of inhibiting angiogenesis of tumors |
US5200397A (en) * | 1990-02-22 | 1993-04-06 | W. R. Grace & Co.-Conn. | Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity |
US5190918A (en) * | 1990-02-22 | 1993-03-02 | W. R. Grace & Co.-Conn. | Peptide fragments and analogs of thrombospondin and methods of use |
DE69827223T2 (de) * | 1997-03-17 | 2006-02-02 | Northwestern University, Chicago | Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen |
ES2307337T3 (es) * | 1998-05-22 | 2008-11-16 | Abbott Laboratories | Medicamentos peptidicos anti-angiogenicos. |
DE60025648T2 (de) * | 1999-11-22 | 2006-09-14 | Abbott Laboratories, Abbott Park | Peptide mit antiangiogener aktivität |
CO5261544A1 (es) * | 1999-11-22 | 2003-03-31 | Abbott Lab | Peptidos n-alquilados que tienen actividad antiangiogenica |
-
2001
- 2001-04-11 US US09/832,733 patent/US20020183242A1/en not_active Abandoned
-
2002
- 2002-04-10 EP EP02731295A patent/EP1429796A4/en not_active Withdrawn
- 2002-04-10 JP JP2002580870A patent/JP2005510452A/ja active Pending
- 2002-04-10 AU AU2002303278A patent/AU2002303278A1/en not_active Abandoned
- 2002-04-10 PE PE2002000292A patent/PE20021078A1/es not_active Application Discontinuation
- 2002-04-10 CA CA002443733A patent/CA2443733A1/en not_active Abandoned
- 2002-04-10 UY UY27254A patent/UY27254A1/es not_active Application Discontinuation
- 2002-04-10 WO PCT/US2002/011027 patent/WO2002083065A2/en not_active Application Discontinuation
- 2002-04-10 BR BRPI0205983-5A patent/BR0205983A/pt not_active IP Right Cessation
- 2002-04-10 MX MXPA03009278A patent/MXPA03009278A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1429796A4 (en) | 2005-01-12 |
UY27254A1 (es) | 2002-11-29 |
BR0205983A (pt) | 2006-05-23 |
CA2443733A1 (en) | 2002-10-24 |
WO2002083065A2 (en) | 2002-10-24 |
PE20021078A1 (es) | 2002-12-18 |
EP1429796A2 (en) | 2004-06-23 |
US20020183242A1 (en) | 2002-12-05 |
AU2002303278A1 (en) | 2002-10-28 |
JP2005510452A (ja) | 2005-04-21 |
WO2002083065A3 (en) | 2004-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03009278A (es) | Farmacos antiangiogenicos peptidos. | |
MXPA04003333A (es) | Remodelado y glicoconjugacion de peptidos. | |
IL232501A (en) | Peptide or polypeptide-resistant protein analogs and their uses | |
MY138074A (en) | Somatostatin analogues | |
EP1402001A4 (en) | Antimicrobial peptides and compounds | |
ATE396204T1 (de) | Peptide als antiangiogene arzneimittel | |
MXPA03010684A (es) | Peptidos y el uso de los mismos para oscurecer la piel. | |
MY126868A (en) | Suspension comprising oxcarbazepine | |
WO2001058470A3 (en) | Methods for enhancing the bioavailability of a drug | |
GB9929464D0 (en) | Complementary peptide ligande generated from the human genome | |
GB0100196D0 (en) | Peptides | |
HK1050012A1 (en) | Peptides having antiangiogenic activity | |
ZA200700168B (en) | Remodeling and glycoconjugation of peptides | |
EP1385556A4 (en) | PEPTIDE CONJUGATES WITH AFFINITY FOR GASTRIN RECEPTORS | |
GB0104752D0 (en) | Pharmaceutical compositions | |
IL162333A0 (en) | Peptides inhibiting prions | |
IL150458A0 (en) | Novel haptotactic peptides | |
SG142165A1 (en) | Biologically active peptides | |
MY145375A (en) | Pharmaceutical composition | |
GB0109438D0 (en) | Peptides | |
SI1173194T1 (en) | Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation | |
MY136343A (en) | Peptides for treatment of cancer | |
IL158411A0 (en) | Peptides that inhibit viral infections and compositions containing the same | |
EP1458736A4 (en) | RECOMBINANT RINDER THROMBIN | |
HK1065782A1 (en) | Compositions comprising higher diamondoids and processes for their separation |